Augmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi.

TitleAugmenting immune responses to varicella zoster virus in older adults: a randomized, controlled trial of Tai Chi.
Publication TypeJournal Article
Year of Publication2007
AuthorsIrwin MR, Olmstead R, Oxman MN
JournalJ Am Geriatr Soc
Volume55
Issue4
Pagination511-7
Date Published2007 Apr
ISSN0002-8614
KeywordsAged, Aged, 80 and over, Chickenpox Vaccine, Female, Geriatrics, Herpes Zoster, Herpesvirus 3, Human, Humans, Immunity, Cellular, Male, Middle Aged, Social Support, Tai Ji
Abstract

OBJECTIVES: To evaluate the effects of a behavioral intervention, Tai Chi, on resting and vaccine-stimulated levels of cell-mediated immunity (CMI) to varicella zoster virus (VZV) and on health functioning in older adults.

DESIGN: A prospective, randomized, controlled trial with allocation to two arms (Tai Chi and health education) for 25 weeks. After 16 weeks of intervention, subjects were vaccinated with VARIVAX, the live attenuated Oka/Merck VZV vaccine licensed to prevent varicella.

SETTING: Two urban U.S. communities between 2001 and 2005.

PARTICIPANTS: A total of 112 healthy older adults aged 59 to 86.

MEASUREMENTS: The primary endpoint was a quantitative measure of VZV-CMI. Secondary outcomes were scores on the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36).

RESULTS: The Tai Chi group showed higher levels of VZV-CMI than the health education group (P<.05), with a significant rate of increase (P<.001) that was nearly twice that found in the health education group. Tai Chi alone induced an increase in VZV-CMI that was comparable in magnitude with that induced by varicella vaccine, and the two were additive; Tai Chi, together with vaccine, produced a substantially higher level of VZV-CMI than vaccine alone. The Tai Chi group also showed significant improvements in SF-36 scores for physical functioning, bodily pain, vitality, and mental health (P<.05).

CONCLUSION: Tai Chi augments resting levels of VZV-specific CMI and boosts VZV-CMI of the varicella vaccine.

DOI10.1111/j.1532-5415.2007.01109.x
Alternate JournalJ Am Geriatr Soc
PubMed ID17397428
Grant ListR01-AG18367 / AG / NIA NIH HHS / United States
R21-AT00255 / AT / NCCIH NIH HHS / United States